Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $152,748 | 90 | 69.9% |
| Food and Beverage | $35,919 | 1,550 | 16.4% |
| Travel and Lodging | $14,867 | 34 | 6.8% |
| Consulting Fee | $11,413 | 8 | 5.2% |
| Honoraria | $3,150 | 2 | 1.4% |
| Education | $506.87 | 14 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $94,847 | 163 | $0 (2024) |
| Amgen Inc. | $25,490 | 57 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $21,348 | 102 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $17,152 | 29 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $12,786 | 103 | $0 (2024) |
| ARGENX US, INC. | $6,879 | 23 | $0 (2024) |
| Lundbeck LLC | $6,874 | 63 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $5,665 | 9 | $0 (2022) |
| Allergan, Inc. | $3,331 | 74 | $0 (2022) |
| UCB, Inc. | $2,310 | 94 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,657 | 214 | ABBVIE INC. ($29,771) |
| 2023 | $39,794 | 252 | AbbVie Inc. ($27,546) |
| 2022 | $38,338 | 217 | ABBVIE INC. ($22,644) |
| 2021 | $50,396 | 327 | Biohaven Pharmaceuticals, Inc. ($17,123) |
| 2020 | $17,560 | 164 | Amgen Inc. ($6,404) |
| 2019 | $22,461 | 192 | Amgen Inc. ($15,443) |
| 2018 | $5,900 | 163 | LivaNova USA, Inc. ($1,011) |
| 2017 | $4,496 | 169 | Teva Pharmaceuticals USA, Inc. ($547.39) |
All Payment Transactions
1,698 individual payment records from CMS Open Payments — Page 1 of 68
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/18/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.90 | General |
| 12/17/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $38.81 | General |
| Category: EPILEPSY | ||||||
| 12/12/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Rare Disease | ||||||
| 12/10/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Neuroscience | ||||||
| 12/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $30.44 | General |
| Category: Neurology | ||||||
| 11/27/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Neurology | ||||||
| 11/26/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $29.04 | General |
| 11/21/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $32.04 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $787.50 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $124.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Travel and Lodging | In-kind items and services | $91.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $38.56 | General |
| Category: Narcoplepsy | ||||||
| 11/08/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 558 | 14,922 | $621,295 | $170,943 |
| 2022 | 13 | 580 | 23,596 | $802,452 | $226,140 |
| 2021 | 14 | 667 | 24,902 | $876,757 | $257,729 |
| 2020 | 15 | 963 | 27,274 | $1.1M | $324,207 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 22 | 14,200 | $213,000 | $69,058 | 32.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 198 | 309 | $196,215 | $49,447 | 25.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 97 | 97 | $74,690 | $17,425 | 23.3% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 14 | 42 | $38,475 | $8,418 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 68 | $31,280 | $7,915 | 25.3% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 37 | 41 | $18,154 | $4,907 | 27.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 18 | 44 | $15,400 | $4,442 | 28.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 15 | 18 | $13,626 | $4,284 | 31.4% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 42 | 42 | $7,350 | $1,763 | 24.0% |
| 96137 | Administration of psychological or neuropsychological test, each additional 30 minutes | Office | 2023 | 42 | 42 | $6,930 | $1,656 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 19 | $6,175 | $1,627 | 26.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 29 | 22,800 | $342,000 | $111,365 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 230 | 361 | $229,235 | $54,606 | 23.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 96 | 96 | $73,920 | $17,954 | 24.3% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 17 | 56 | $52,725 | $11,251 | 21.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 27 | 28 | $21,196 | $7,144 | 33.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 27 | 56 | $19,600 | $5,883 | 30.0% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2022 | 33 | 33 | $12,978 | $3,919 | 30.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 35 | $11,970 | $3,260 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 29 | $13,340 | $3,190 | 23.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $10,608 | $2,872 | 27.1% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 12 | 26 | $4,680 | $2,260 | 48.3% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2022 | 29 | 30 | $5,250 | $1,271 | 24.2% |
| 96137 | Administration of psychological or neuropsychological test, each additional 30 minutes | Office | 2022 | 29 | 30 | $4,950 | $1,164 | 23.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 27 | 24,000 | $360,000 | $116,449 | 32.3% |
About Dr. Noor Sachdev, MD
Dr. Noor Sachdev, MD is a Neurology healthcare provider based in San Jose, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1710141072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Noor Sachdev, MD has received a total of $218,603 in payments from pharmaceutical and medical device companies, with $39,657 received in 2024. These payments were reported across 1,698 transactions from 81 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($152,748).
As a Medicare-enrolled provider, Sachdev has provided services to 2,768 Medicare beneficiaries, totaling 90,694 services with total Medicare billing of $979,019. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location San Jose, CA
- Active Since 07/16/2008
- Last Updated 02/27/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710141072
Products in Payments
- UBRELVY (Drug) $48,317
- QULIPTA (Drug) $48,136
- Aimovig (Biological) $25,246
- NURTEC ODT (Drug) $23,041
- AJOVY (Biological) $20,163
- VYVGART (Drug) $6,610
- VYEPTI (Biological) $6,499
- ULTOMIRIS (Biological) $5,721
- Soliris (Drug) $2,563
- Fycompa (Drug) $1,526
- VNS Therapy (Device) $1,258
- TYSABRI (Biological) $1,257
- BOTOX (Biological) $1,002
- Vimpat (Drug) $967.87
- GILENYA (Drug) $840.82
- Briviact (Drug) $755.59
- APTIOM (Drug) $579.59
- Ponvory (Drug) $575.40
- SOLIRIS (Drug) $569.22
- Hizentra (Biological) $506.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in San Jose
Dr. Harmeet Sachdev, Md, MD
Neurology — Payments: $89,445
Said Ibrahimi, Md, MD
Neurology — Payments: $15,209
Dr. Raj Gupta, M.d, M.D
Neurology — Payments: $12,977
Mr. Akshay Shah, M.d, M.D
Neurology — Payments: $8,411
Dr. Angela Anagnos, M.d, M.D
Neurology — Payments: $7,809
Dr. Jennifer Choi, M.d, M.D
Neurology — Payments: $6,111